Air Products Shorts Trim Positions Before Thursday Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Air Products and Chemicals reports fiscal fourth-quarter results on Thursday with short sellers continuing to reduce exposure, even as the stock has outpaced its nearest peer over the past week.
Short interest has fallen to roughly 1.9% of the free float, down 4% over the past week and continuing a retreat from the brief October 1 peak of around 5.3 million shares. That peak has now fully unwound. The borrow market reflects the same indifference: availability runs at nearly 4,000%, meaning shares available to lend vastly outnumber those currently borrowed, and borrowing costs have eased to 0.46%, down about 6% on the week. Options positioning is equally subdued, with the put/call ratio at 0.61, fractionally below its 20-day average and showing no pre-earnings hedging premium.
The stock itself closed at $312.97 on Tuesday, up just under 2% on the week. That compares with a 2.4% gain for Linde, the most closely correlated peer, over the same period. The month has been stronger, with APD up nearly 13% over 30 days, a move that has pushed the price-to-earnings multiple to around 20x and price-to-book to 3.7x.
Analyst opinion has shifted modestly more cautious in the weeks before the print. RBC Capital trimmed its target from $360 to $346 on October 15 while keeping an Outperform rating. Citigroup and UBS both cut targets in early October, to $312 and $305 respectively, though each held a Neutral stance. Barclays moved in the other direction, initiating coverage with an Overweight rating and a $353 target on October 13. The mean target across the consensus sits at $342.55, roughly 9% above the current price, though the gap between the most cautious and most optimistic targets reflects genuine disagreement about valuation after the recent run.
The forward earnings growth factor ranks in the 98th percentile of the ORTEX universe, and the dividend score ranks in the 93rd percentile, two pillars that underpin the bull case. Against that, the EV/EBIT factor ranks in just the 14th percentile, and EPS surprise history ranks in the 3rd, suggesting the company's beat rate has been modest. The print will test whether the 13% one-month re-rating in the shares was supported by the underlying numbers, or whether the gap between the growth outlook and the actual quarterly delivery closes.
Stocks in this article
See the live data behind this article on ORTEX.
Open APD on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 04:03
- Data as of
- 4 Nov 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.